These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37269430)

  • 21. Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice.
    Takanashi S; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2021 Nov; 60(11):5247-5256. PubMed ID: 33682890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study.
    Giollo A; Zen M; Larosa M; Astorri D; Salvato M; Calligaro A; Botsios K; Bernardi C; Bianchi G; Doria A
    Rheumatology (Oxford); 2023 Jun; 62(6):2083-2089. PubMed ID: 36190344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential role of fatigue in difficult-to-treat rheumatoid arthritis.
    Leon L; Freites-Núñez D; Madrid A; Rodriguez-Mariblanca M; Fernandez-Gutierrez B; Abasolo L
    BMC Rheumatol; 2024 Sep; 8(1):49. PubMed ID: 39350299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis.
    Yoshii I; Sawada N; Chijiwa T
    Rheumatol Int; 2022 Nov; 42(11):1947-1954. PubMed ID: 35410410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inappropriate treatment response to DMARDs: A pathway to difficult-to-treat rheumatoid arthritis.
    Guo H; Li L; Liu B; Lu P; Cao Z; Ji X; Li L; Ouyang G; Nie Z; Lyu A; Lu C
    Int Immunopharmacol; 2023 Sep; 122():110655. PubMed ID: 37481847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps.
    Tan Y; Buch MH
    RMD Open; 2022 Jul; 8(2):. PubMed ID: 35896282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping study.
    Roodenrijs NMT; van der Goes MC; Welsing PMJ; van Oorschot EPC; Nikiphorou E; Nijhof NC; Tekstra J; Lafeber FPJG; Jacobs JWG; van Laar JM; Geenen R
    Rheumatology (Oxford); 2021 Nov; 60(11):5105-5116. PubMed ID: 33560301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difficult-to-treat rheumatoid arthritis: Current concept and unsolved problems.
    Watanabe R; Okano T; Gon T; Yoshida N; Fukumoto K; Yamada S; Hashimoto M
    Front Med (Lausanne); 2022; 9():1049875. PubMed ID: 36353219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis.
    Philippoteaux C; Marty-Ane A; Cailliau E; Labreuche J; Philippe P; Cortet B; Paccou J; Flipo RM; Letarouilly JG
    Semin Arthritis Rheum; 2023 Dec; 63():152275. PubMed ID: 37852155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial.
    Seegobin SD; Ma MH; Dahanayake C; Cope AP; Scott DL; Lewis CM; Scott IC
    Arthritis Res Ther; 2014 Jan; 16(1):R13. PubMed ID: 24433430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
    Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
    J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients.
    Morris NT; Brook J; Ben-Artzi A; Martin W; Kermani TA; Avedikian-Tatosyan L; Karpouzas G; Nagam H; Navarro G; Choi S; Taylor MB; Elashoff D; Kaeley GS; Ranganath VK
    Clin Rheumatol; 2021 Dec; 40(12):5055-5065. PubMed ID: 34269927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
    Lutf A; Poil AR; Hammoudeh M
    Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.
    Durán J; Combe B; Niu J; Rincheval N; Gaujoux-Viala C; Felson DT
    Rheumatology (Oxford); 2015 Dec; 54(12):2166-70. PubMed ID: 26175470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis.
    Bertsias A; Flouri ID; Repa A; Avgoustidis N; Kalogiannaki E; Pitsigavdaki S; Bertsias G; Sidiropoulos P
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38242549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
    Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
    Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.
    Martin WJ; Shim M; Paulus HE; Chaudhari S; Feng J; Elashoff D; Hahn TJ; Ranganath VK;
    J Clin Rheumatol; 2014 Sep; 20(6):301-5. PubMed ID: 25160011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study.
    Courvoisier N; Dougados M; Cantagrel A; Goupille P; Meyer O; Sibilia J; Daures JP; Combe B
    Arthritis Res Ther; 2008; 10(5):R106. PubMed ID: 18771585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of treat-to-target strategies on bone erosion progression in early rheumatoid arthritis: An HR-pQCT study.
    Yue J; Griffith JF; Xu J; Xiao F; Shi L; Wang D; Wong PCH; Li EK; Li M; Li TK; Mak WY; Zhu TY; Hung VW; Qin L; Tam LS
    Semin Arthritis Rheum; 2018 Dec; 48(3):374-383. PubMed ID: 29858113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment.
    Miwa Y; Takahashi R; Ikari Y; Maeoka A; Nishimi S; Oguro N; Hayashi T; Hatano M; Isojima S; Yanai R; Kasama T; Toyoshima Y; Inagaki K; Sanada K
    Intern Med; 2017; 56(8):903-906. PubMed ID: 28420837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.